Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07566130
PHASE1

A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

The objectives for this 2 Part study are to assess the safety, tolerability, and pharmacokinetics following single ascending oral doses of nacresertib in healthy adult participants (Part 1) and to assess the safety, tolerability, and pharmacokinetics following multiple ascending oral doses in healthy adult participants (Part 2).

Official title: A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Ascending Oral Doses of Nacresertib in Healthy Adult Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

93

Start Date

2025-04-18

Completion Date

2026-05-07

Last Updated

2026-06-04

Healthy Volunteers

Yes

Interventions

DRUG

nacresertib

Oral

DRUG

Placebo

Oral

Locations (1)

Acpru /Id# 274374

Grayslake, Illinois, United States